The Microbiota-Gut-Brain Axis: Clinical Applications in Obesity and Type 2 Diabetes

11Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abstract: Recent investigations highlight the importance of the gut microbiota and bacteria-derived metabolites as key components in obesity and metabolic health. The microbiota-gut-brain axis presents promising targets for future obesity treatments and prevention. However, the current state of evidence and existing clinical applications of the microbiota-gut-brain axis have yet to be summarized in a thorough review. Therefore, we sought to examine current evidence on the effect of lifestyle, dietary, pharmacological, and surgical interventions on the microbiota-gut-brain axis. In addition, this review highlights potential next steps in research toward characterizing the role of the microbiota-gut-brain axis in metabolic health, along with possible interventions to address obesity.

Cite

CITATION STYLE

APA

Moser, B., Milligan, M. A., & Dao, M. C. (2022). The Microbiota-Gut-Brain Axis: Clinical Applications in Obesity and Type 2 Diabetes. Revista de Investigacion Clinica; Organo Del Hospital de Enfermedades de La Nutricion. NLM (Medline). https://doi.org/10.24875/RIC.22000197

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free